Ongoing investigations into semaglutide are uncovering exciting capabilities beyond current use for type 2 diabetes mellitus. Scientists are thoroughly investigating how this GLP-1 receptor agonist affects weight management, heart health, and possibly brain health. These findings point to a wide spectrum of therapeutic opportunities, fueling add… Read More